AI FOR DRUG DISCOVERY

AI for Drug Discovery” is a timely and transformative initiative designed to address long-standing challenges in the pharmaceutical industry. Traditional drug discovery approaches are often costly, time-consuming and uncertain, requiring years of research with no guarantee of success. Moreover, every stage of the process demands continuous technological advancement and significant human effort. With the rise of Artificial Intelligence a new paradigm in drug development is emerging. AI-driven drug discovery is not just an innovation—it has become a practical necessity to overcome existing barriers in pharmaceutical research. Advanced algorithms, predictive models and large-scale data analytics now allow researchers to analyse complex biological data with unprecedented speed and accuracy. The proposed AI-based platform empowers scientists to identify hidden therapeutic targets more efficiently and supports early, accurate assessment of drug safety and efficacy. By reducing uncertainty in the initial stages, the platform significantly increases the likelihood of successful outcomes in later clinical trials. The successful implementation of this project promises far-reaching benefits. For the pharmaceutical industry it offers reduced development costs, shorter timelines, higher clinical success rates and a stronger pipeline of innovative therapies. While challenges remain the potential of the platform far outweighs its limitations. The approach is both technically feasible and economically sustainable. AI in drug discovery is poised to play a defining role in the future of healthcare by fundamentally transforming how medicines are researched, developed and delivered.

[1]        Ekins S. Puhl A.C. Zorn K.M. et al. (2019). Exploiting Machine Learning for End-to-End Drug Discovery. Nat. Mater. 18 435–441. [2]        Schneider G. (2018). Automating Drug Discovery. Nat. Rev. Drug Discov. 17 97–113. [3]        Stokes J.M. Yang K. Swanson K. et al. (2020). A Deep Learning Approach to Antibiotic Discovery. Cell 180(4) 688–702. [4]        Mamoshina P. Vieira A. Putin E. Zhavoronkov A. (2016). Applications of Deep Learning in Biomedicine. Mol. Pharm. 13 1445–1454. [5]        Li X. Fourches D. (2020). Inductive Transfer Learning for Molecular Activity Prediction: A Review. J. Chem. Inf. Model. 60 5580–5597